Enlarge / Moderna CEO Stephane Bancel throughout a Bloomberg Tv interview on the closing day of the World Financial Discussion board in Davos, Switzerland, on Could 26, 2022. (credit score: Getty | Jason Alden)
In contrast with different international locations, the US is once more seeing exorbitant costs for a medication—even one it helped develop.
Within the present COVID-19 booster marketing campaign, the Facilities for Illness Management and Prevention is paying round $82 for every dose of Moderna’s 2023–2024 up to date mRNA COVID-19 vaccine for its program to offer vaccine for the uninsured. That worth is slightly over thrice the $26 per dose the federal authorities paid for the final up to date booster, which was completely distributed by the federal government.
The worth hike marks the vaccine’s transfer from federal distribution to the business market. Moderna and rival producer Pfizer raised the US record worth of their COVID-19 vaccines by roughly 400 %. (Moderna’s is listed at $128 and Pfizer’s is $115).
Learn eight remaining paragraphs | Feedback
